Abstract
Opioid-induced constipation (OIC) is a commonly experienced side effect of those utilizing narcotic pain medication. The current treatment for OIC commonly consists of stool softeners and bowel stimulants which often leads to abdominal bloating and discomfort ultimately resulting in uncomfortable bowel movements and loose stools. We present a novel approach to the treatment of acute OIC after abdominoplasty in patients taking narcotic pain medication utilizing a well-known medication currently approved by the Food and Drug Administration for the treatment of OIC in adult patients with chronic noncancer pain.
Get full access to this article
View all access options for this article.
